disease profiles MSK Flashcards
what is osteoporosis
reduced bone mineral density and increased porosity
what comes as a result of osteoporosis
increased fragility and fracture risk
normal quality of bone just not enough of it
osteoporosis
risk factors of osteoporosis
smoking, poor diet, female, inactivity, increased alcohol intake and lack of sunlight exposure
what is the intermediate stage of osteoporosis
osteopenia
what is type 1 osteoporosis
post menopausal
what is type 2 osteoporosis
osteoporosis of old age
what type of fractures dominate osteoporosis type 2
neck and vertebral fractures
how to diagnose osteoporosis
DEXA scanning
how to treat (slow process) of osteoporosis
calcium and vit D supplements
abnormal softening of bone due to deficient minerilisation of osteoid secondary to inadequate amounts of calcium and phosphorus
osteomalacia
what is an osteoid
immature bone
what is osteomalacia in children known as
rickets
what are the causes of osteomalacia and rickets
insufficinet calcium and phosphate deficiency
how can there by a lack of calcium
lack of absorption in intestine or resistance to action of vit D
how does phosphate deficiency happen
increased renal losses
what is the presentation of osteomalacia and rickets
pain, deformities from soft bone, pathological fractures, symptoms of hypocalcaemia
how to treat osteomalacia and rickets
vit D therapy with calcium and phosphate supplementation
what is hyperparathyroidism
over activity of parathyroid glands with high levels of PTH
what is primary hyperparathyroidism due to
benign adenoma, hyperplasia or rarely a malignant neoplasia
labs of someone with primary hyperparathyroidism
raised serum PTH, raised Ca, phosphate low or normla
what is secondary hyperparathyroidism due to
physiologial overproduction of PTH secondary to hypocalceamia
what is secondary hyperparathyroidism caused by
vit D deficincy or chronic kidney disease
what is tertiary hyperparathyroidism due to
people with chronic secondary who develop adenoma which continues to produce PTH despite biochemical correction
what is renal dystrophy
reduced phosphate excretion and inactive activation of Vitamin D
what does renal dystrophy lead to
secondary hyperparathyroidism with subsequent osteomalacia, sclerosis of bone and calcification of soft tissues
what is pagets disease
a chronic disorder resulting in thickened britter and misshapen bones
labs of pagets disease
serum alk phos is raised whilsy calcium and phsphorus are usually normal
how to treat pagets disease
with biphosphonates or calitonin
what is rheumatoid arthritis
symmetrical inflammatory polyarthtritis affecting mainly the peripheral joints which if untreated can potentially lead to joint damage and irreversible deformities and increased morbidity and mortality
prevalence of RA in men and women
3x more common in women
prevalence of RA in the UK
1%
what is RA mediated by
HLA -DR4
cause of RA
unknown
trigger of RA
infections, stress, cigarette smoking
severity of RA depends on
genetic factors, presence of auto antibodies
what is the main structure involved in RA
synovium
what does the synovium line
the inside of the synovial joint capsules and tendon sheaths
what joints in the spine are synovial fluid lined
C1/C2
what joints are usually affected by RA
hand joints, wrists, elbows, shoulders, TMJs, knees, hips, ankles, feet
difference between osteoarthritis and RA
osteoarthritis is when bone ends rub together and RA is when a swollen inflamed synovial membrane causes bone erosion
inflamed synovial is called
pannus
what happens when panes is in contact with bone
osteoclast is activated causing bone erosion
what is released from macrophage in RA
TNFa, IL1 and IL6
what is released from B cells in RA
RF and IL 6
what do the activation of pro inflammatory cytokines lead to in RA
- activation of synoviocytes to cause the hypertrophic synovium / pannus
- activation of osteoclasts
- inhibition of chondrocytes
- stimulation of angiogenesis
what drugs inhibit TNFa
infliximab, etanercept, adalimumab, certolizumab, golimumab
what drugs inhibit iL1-
anakinra
what drugs inhibit the IL6 receptor
tocilizumab
presentation of RA
pain and swelling in symmetrical fashion affecting peripheral synovial joints, typically small joints of hands and feet, prolonged morning stiffness, monoarthritis (rare), tenosynovitis, trigger finger, carpal tunnel, palindromic, systemic symptoms, poor grip strength
what test can be used of the detection of synovitis in RA
squeeze test
what is tenosynovitis
inflammation of the tendon sheath
what is trigger finger
fingers lock
palindromic
episodic RA
lung manifestations of RA
Plueral effusion, rheumatoid nodules
heart manifestations of RA
pericarditis, pericardial effusions
neurological manifestations of RA
peripheral neuropathy, carpal tunnel syndrome
leg ulcers associated with RA
arterial
diagnosis of RA
mainly clinical, peripheral symmetrical polyarthtritis affecting hands and feet, raised inflammatory markers, antibody testing not always positive, imaging
autoantibodies in RA
rheumatoid factor (rheumatoid IgM), antiCCP antibodies
what autoantibody in RA is more specific
Anti CCP
what autoantibody has low sensitivity in RA
anti CCP
score for disease activity in RA
DAS 28
management of RA
early diagnosis, disease modifying anti rheumatic drugs, NSAIDs and steroids, education
what is early RA defined as
less than 2 years since symptom onset
therapeutic window of opportunity in RA
first 3 months
first line for RA
education, rest, exercise, social services, salicylates, NSAIDs
second line for RA
gold salts, hydroxychloroquine
third line for RA
MTX, penicillin amine, AZA
last line for RA
cytotoxic agents and experimental drugs
examples of DMARD
methotrexate, sufasalazine, hydrochloroquine, leflunomide, steroids
what can methotrexate cause in the lungs
pneumonitis
who to avoid methotrexate with
people with lung disease
less than 2.6 DAS28 scoring
remission
2.6-3.2 DAS28 scoring
low disease activity
3.2-5.1 DAS28 scoring
moderate disease activity
more than 5.1 DAS28 scoring
active disease
what DAS28 score qualifies for biologic therapy
3.2 inspite of 2 DMARDs
what is osteoarthritis
a chronic disease characterised by cartilage loss and accompanying periarticular damage
what are the most affected joints in osteoarthritis
knees, hands and hips
what is the pathophysiology of OA
metabolically active dynamic process that involves all joint tissues
what are the key pathological changes in OA
localised loss of hyaline cartilage and remodelling of adjacent bone with new bone formation at joint margins
what indicates a repair process of synovial joints
combination of tissue loss and new tissue synthesis
risk factors of OA
genetic, ageing, female, obesity, biomechanics
features of a OA joint
subchondral bone cyst, thickened joint capsule, episodic synovitis, fibrillated cartilage, osteophyte, degenerative cartilage loss, subchondral bone sclerosis
localised OA
can effect hips, knees, finger interphalangeal joints, facet joins of lower cervical and lower lumbar spines
generalised OA
defined as OA at either the spinal or hand joints and in atleast 2 other joint regions
what does the presence of multiple heberdens nodes indicate
a subset of OA involving DIP joints, thumb bases, first MTP joints, lower lumbar and cervical facet joints, knees and hips
joints most affected by OA
neck, lower back, hips, base of thumb, finger joints, knee, base of toe
examination features of OA
joint line tenderness, crepitus, joint effusion, bony swelling, deformity, limitation of motion
where is heberdens node found
top of fingers
where is bouchards node found
bottom of fingers
presentation of knee OA
osteophytes, effusions, crepitus, restriction in movement, genuflects varies and valgus deformities, bakers cysts
distribution of hip OA
pain felt radiating to knee or groin, pain in hip can be radiating from lower back, hip movement restricted
distribution of spine OA
cervical - pain and restriction of movement , occipital headaches, osteophytes may impinge on nerve roots
lumbar - osteophytes can cause spinal stenosis if they encroach on the spinal canal q
diagnosis of spinal OA
clinical, imaging
what would u see on a OA x ray
marginal osteophytes, joint space narrowing, subchondral sclerosis, subchondral cysts
management of OA
education, lifestyle, physiotherapy, occupation therapy, analgesia, local intra articular steroid infections
surgical management of OA
joint replacements arthroscopic surgery to remove loose bodies
what are crystal arthropathies
a diverse group of disorders characterised by the deposition of various minerals in joints and soft tissues leading to inflammation
types of crystal arthropathies
gout monosodium urate crystals, pseudogount calcium pyrophosphate crystal deposition, hydroxyapatite - basic calcium phosphate deposition
define gout
a potentially disabling and erosive inflammatory arthritis caused by deposition of monosodium urate crystals into joints and soft tissues
prevalence of gout
2.49%
prevalence of gout in men vs women
more common in men
causes of hyperuricaemia
increased urate production and reduced urate excretion
what causes increase urate production
inherited enzyme defects, myeloproliferative / lymphoproliferative disorders, psoriasis, alcohol, high dietary purine intake
what causes reduced urate excretion
chronic renal impairment, volume depletion, hypothyroidism, diuretics, cytotoxic
how long does acute gout usually last
3 days with treatment, 10 days without
what is chronic tophaceous gout associated with
diuretics
investigations of gout
serum uric acid is raised, raised inflammatory markers, polarised microscopy synovial fluid, renal impairment, x rays
treatment of acute gout
NSAIDs, cohcicine, steroids, lifestyle modification
preventative measures for gout
Xanthine oxidase inhibitors - allopurinolm febuxostat, uricosuirc drugs - sulfinpyrzone, prodenecid, benzbromarone,
when should you start preventive treatment for gout
1 week after acute attack
WHO target for serum uric acid
300-360 mol/L
indications for prophylactic treatment of gout
one or more attacks of gout in a year inspite of lifestyle modifications, presence of gouty tophi or signs of gouty arthritis, uric acid calculi, chronic renal impairment, heart failure where unable to stop diuretics, chemo therapy patients who develop gout
who is pseudo gout most common in
elderly
what is pseudo gout also known as
calcium pyrophosphate deposition disease
treatment of pseudo gout
NSAIDS, cochincine, steroids rehydration
what is hydroxyapatite
crystal deposition in or around the joint
treatment of hyrocyapaitie
NSAIDs, intra articular steroid injection, physiotherapy, partial or total arthroplasty
what does hydroxyapatite lead to the release of
collagenases, serine proteinases and IL-1
what is soft tissue rheumatism
pain that is caused by inflammation/damage to ligaments, tendons, muscles or nerve near a joint rather than bone or cartilage
generalised soft tissue pain
fibromyalgia
what is the most common area for soft tissue pain
shoulder
investigation of soft tissue rheumatism
clinical history and examination, Xray, US, MRI, identify precipitating factors
treatment of soft tissue rheumatism
pain control, rest and ice compression, PT, steroid injections surgery
prevalence of joint hyper mobility syndrome in men and women
women more than men
genetic syndromes leading to joint hypermobility syndrome
marfans, Ehlers danlos syndrome
when does joint hyper mobility syndrome tend to present
childhood or 3rd decade
signs and symptoms of jointer hypermobility syndrome
joint pains, joint stiffness, foot and ankle pain, neck and backaches frequent sprains and dislocations, thin stretchy skin
what scoring system is used for hypermobility syndrome
beighton score
what score on the Brighton score constitutes a diagnosis
> 4/9
treatment of joint hypermobility syndrome
patient education, physiotherapy, analgesiA
what are connective tissue diseases
conditions associated with spontaenous overactivity of the immune system
what is present in connective tissue disease
auto antibodies
types of CTD
SLE, sjogrens syndrome, systemic scleoriss, dermatomyositis, polymyositis, anti phospholipid syndrome
what is SLE
an auto immune condition that can affect most organ systems
pathophysiology of SLE
immune system attcks cells causing inflammation and tissue damage
ratio of female to male prevelance of SLE
9:1
when does SLE present
at child bearing women
pathogenesis of SLE
defective apoptosis leading to cell contents float about for longer than normal allowing the immune system to start to develop a reaction against them so the cell contents are seen as antigens (autoantigens), immune cells trigger a response which means over time there are antbodies against these antigens which then start to recognise antigens within normal cells and attack them this causes immune complexes to form and they get deposited in skin, blood vessel walls of kidneys and that deposition activates the complement cascade causing focused inflammation in certain areas causing necrosis and fibrosis causing organ damage
SLE score
EULAR/ACR